Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Telix Pharmaceuticals Ltd. has updated its Securities Dealing Policy as of December 2024, aligning with ASX Listing Rule 12.10. This biopharmaceutical company, known for its focus on innovative radiopharmaceuticals, continues to capture attention in the financial markets with its international operations and promising oncology products.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.